Semiconductors
Compare Stocks
2 / 10Stock Comparison
NA vs CLSK
Revenue, margins, valuation, and 5-year total return — side by side.
Software - Application
NA vs CLSK — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Semiconductors | Software - Application |
| Market Cap | $140M | $3.58B |
| Revenue (TTM) | $24M | $785M |
| Net Income (TTM) | $-63M | $-261M |
| Gross Margin | 48.8% | 41.4% |
| Operating Margin | -322.5% | -26.4% |
| Forward P/E | 0.0x | 12.5x |
| Total Debt | $199M | $824M |
| Cash & Equiv. | $32M | $43M |
NA vs CLSK — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Jul 22 | May 26 | Return |
|---|---|---|---|
| Nano Labs Ltd (NA) | 100 | 2.2 | -97.8% |
| CleanSpark, Inc. (CLSK) | 100 | 350.4 | +250.4% |
Price return only. Dividends and distributions are not included.
Quick Verdict: NA vs CLSK
Each card shows where this stock fits in a portfolio — not just who wins on paper.
NA is the clearest fit if your priority is income & stability and sleep-well-at-night.
- beta 1.37
- Lower volatility, beta 1.37, Low D/E 85.4%, current ratio 1.75x
- Beta 1.37, current ratio 1.75x
CLSK carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.
- Rev growth 102.2%, EPS growth 262.3%, 3Y rev CAGR 79.9%
- -84.3% 10Y total return vs NA's -98.3%
- 102.2% revenue growth vs NA's -48.2%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 102.2% revenue growth vs NA's -48.2% | |
| Value | Lower P/E (0.0x vs 12.5x) | |
| Quality / Margins | -33.2% margin vs NA's -261.0% | |
| Stability / Safety | Beta 1.37 vs CLSK's 3.39 | |
| Dividends | 0.2% yield; 2-year raise streak; the other pay no meaningful dividend | |
| Momentum (1Y) | +74.1% vs NA's -52.2% | |
| Efficiency (ROA) | -4.3% ROA vs CLSK's -8.5%, ROIC -30.4% vs 10.3% |
NA vs CLSK — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
NA vs CLSK — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
CLSK leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
CLSK is the larger business by revenue, generating $785M annually — 32.5x NA's $24M. Profitability is closely matched — net margins range from -33.2% (CLSK) to -2.6% (NA). On growth, CLSK holds the edge at +11.6% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $24M | $785M |
| EBITDAEarnings before interest/tax | -$66M | $181M |
| Net IncomeAfter-tax profit | -$63M | -$261M |
| Free Cash FlowCash after capex | -$117M | -$1.0B |
| Gross MarginGross profit ÷ Revenue | +48.8% | +41.4% |
| Operating MarginEBIT ÷ Revenue | -3.2% | -26.4% |
| Net MarginNet income ÷ Revenue | -2.6% | -33.2% |
| FCF MarginFCF ÷ Revenue | -4.9% | -133.1% |
| Rev. Growth (YoY)Latest quarter vs prior year | -66.5% | +11.6% |
| EPS Growth (YoY)Latest quarter vs prior year | +50.0% | -2.6% |
Valuation Metrics
CLSK leads this category, winning 2 of 3 comparable metrics.
Valuation Metrics
| Metric | ||
|---|---|---|
| Market CapShares × price | $140M | $3.6B |
| Enterprise ValueMkt cap + debt − cash | $165M | $4.4B |
| Trailing P/EPrice ÷ TTM EPS | -8.44x | 12.48x |
| Forward P/EPrice ÷ next-FY EPS est. | 0.03x | — |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | — | 6.53x |
| Price / SalesMarket cap ÷ Revenue | 23.48x | 4.67x |
| Price / BookPrice ÷ Book value/share | 4.09x | 2.04x |
| Price / FCFMarket cap ÷ FCF | — | — |
Profitability & Efficiency
NA leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
NA delivers a -10.2% return on equity — every $100 of shareholder capital generates $-10 in annual profit, vs $-14 for CLSK. CLSK carries lower financial leverage with a 0.38x debt-to-equity ratio, signaling a more conservative balance sheet compared to NA's 0.85x. On the Piotroski fundamental quality scale (0–9), CLSK scores 5/9 vs NA's 4/9, reflecting solid financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | -10.2% | -13.7% |
| ROA (TTM)Return on assets | -4.3% | -8.5% |
| ROICReturn on invested capital | -30.4% | +10.3% |
| ROCEReturn on capital employed | -38.3% | +13.7% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 5 |
| Debt / EquityFinancial leverage | 0.85x | 0.38x |
| Net DebtTotal debt minus cash | $166M | $781M |
| Cash & Equiv.Liquid assets | $32M | $43M |
| Total DebtShort + long-term debt | $199M | $824M |
| Interest CoverageEBIT ÷ Interest expense | -5.56x | -18.49x |
Total Returns (Dividends Reinvested)
CLSK leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in CLSK five years ago would be worth $7,306 today (with dividends reinvested), compared to $172 for NA. Over the past 12 months, CLSK leads with a +74.1% total return vs NA's -52.2%. The 3-year compound annual growth rate (CAGR) favors CLSK at 48.8% vs NA's -42.2% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | -36.9% | +21.0% |
| 1-Year ReturnPast 12 months | -52.2% | +74.1% |
| 3-Year ReturnCumulative with dividends | -80.7% | +229.7% |
| 5-Year ReturnCumulative with dividends | -98.3% | -26.9% |
| 10-Year ReturnCumulative with dividends | -98.3% | -84.3% |
| CAGR (3Y)Annualised 3-year return | -42.2% | +48.8% |
Risk & Volatility
Evenly matched — NA and CLSK each lead in 1 of 2 comparable metrics.
Risk & Volatility
NA is the less volatile stock with a 1.37 beta — it tends to amplify market swings less than CLSK's 3.39 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CLSK currently trades 59.2% from its 52-week high vs NA's 6.6% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.37x | 3.39x |
| 52-Week HighHighest price in past year | $31.48 | $23.61 |
| 52-Week LowLowest price in past year | $1.58 | $7.91 |
| % of 52W HighCurrent price vs 52-week peak | +6.6% | +59.2% |
| RSI (14)Momentum oscillator 0–100 | 39.6 | 71.5 |
| Avg Volume (50D)Average daily shares traded | 82K | 19.0M |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
Wall Street rates NA as "Buy" and CLSK as "Buy". CLSK is the only dividend payer here at 0.24% yield — a key consideration for income-focused portfolios.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy |
| Price TargetConsensus 12-month target | — | $20.21 |
| # AnalystsCovering analysts | 23 | 10 |
| Dividend YieldAnnual dividend ÷ price | — | +0.2% |
| Dividend StreakConsecutive years of raises | — | 2 |
| Dividend / ShareAnnual DPS | — | $0.03 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +4.1% |
CLSK leads in 3 of 6 categories (Income & Cash Flow, Valuation Metrics). NA leads in 1 (Profitability & Efficiency). 1 tied.
NA vs CLSK: Frequently Asked Questions
8 questions · data-driven answers · updated daily
01Is NA or CLSK a better buy right now?
For growth investors, CleanSpark, Inc.
(CLSK) is the stronger pick with 102. 2% revenue growth year-over-year, versus -48. 2% for Nano Labs Ltd (NA). CleanSpark, Inc. (CLSK) offers the better valuation at 12. 5x trailing P/E, making it the more compelling value choice. Analysts rate Nano Labs Ltd (NA) a "Buy" — based on 23 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — NA or CLSK?
Over the past 5 years, CleanSpark, Inc.
(CLSK) delivered a total return of -26. 9%, compared to -98. 3% for Nano Labs Ltd (NA). Over 10 years, the gap is even starker: CLSK returned -84. 3% versus NA's -98. 3%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — NA or CLSK?
By beta (market sensitivity over 5 years), Nano Labs Ltd (NA) is the lower-risk stock at 1.
37β versus CleanSpark, Inc. 's 3. 39β — meaning CLSK is approximately 148% more volatile than NA relative to the S&P 500. On balance sheet safety, CleanSpark, Inc. (CLSK) carries a lower debt/equity ratio of 38% versus 85% for Nano Labs Ltd — giving it more financial flexibility in a downturn.
04Which is growing faster — NA or CLSK?
By revenue growth (latest reported year), CleanSpark, Inc.
(CLSK) is pulling ahead at 102. 2% versus -48. 2% for Nano Labs Ltd (NA). On earnings-per-share growth, the picture is similar: CleanSpark, Inc. grew EPS 262. 3% year-over-year, compared to 61. 1% for Nano Labs Ltd. Over a 3-year CAGR, CLSK leads at 79. 9% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — NA or CLSK?
CleanSpark, Inc.
(CLSK) is the more profitable company, earning 47. 6% net margin versus -278. 8% for Nano Labs Ltd — meaning it keeps 47. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CLSK leads at 41. 6% versus -242. 7% for NA. At the gross margin level — before operating expenses — CLSK leads at 41. 6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Which pays a better dividend — NA or CLSK?
In this comparison, CLSK (0.
2% yield) pays a dividend. NA does not pay a meaningful dividend and should not be held primarily for income.
07Is NA or CLSK better for a retirement portfolio?
For long-horizon retirement investors, Nano Labs Ltd (NA) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding.
CleanSpark, Inc. (CLSK) carries a higher beta of 3. 39 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (NA: -98. 3%, CLSK: -84. 3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
08What are the main differences between NA and CLSK?
Both stocks operate in the Technology sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: NA is a small-cap quality compounder stock; CLSK is a small-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.